CODX vs HCA
Co-Diagnostics, Inc. Common Stock (CODX) versus HCA Holdings Inc (HCA) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
HCA Holdings Inc (HCA) is a medical care facilities company listed on US.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported HCA revenue for 2025-12-31 was $75.60B. Net income was $6.78B. Revenue was up 7.1% from 2024-12-31 to 2025-12-31. HCA currently screens at market cap $91.01B and trailing P/E 16.8.
CODX currently screens at market cap $31.4M. HCA currently screens at market cap $91.01B and trailing P/E 16.8.
Not investment advice. Open the CODX and HCA stock pages for the full models.
Not investment advice.